In CML the Bcr-Abl gene enhances the cell proliferation by activating the ERK and pAkt pathways and by inhibiting the p38 and JNK pathways [1]. Here, MAPK8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.